These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 16547245)

  • 41. Consistent patterns in the development and immunodominance of human immunodeficiency virus type 1 (HIV-1)-specific CD8+ T-cell responses following acute HIV-1 infection.
    Yu XG; Addo MM; Rosenberg ES; Rodriguez WR; Lee PK; Fitzpatrick CA; Johnston MN; Strick D; Goulder PJ; Walker BD; Altfeld M
    J Virol; 2002 Sep; 76(17):8690-701. PubMed ID: 12163589
    [TBL] [Abstract][Full Text] [Related]  

  • 42. T cell receptor usage and fine specificity of human immunodeficiency virus 1-specific cytotoxic T lymphocyte clones: analysis of quasispecies recognition reveals a dominant response directed against a minor in vivo variant.
    Kalams SA; Johnson RP; Dynan MJ; Hartman KE; Harrer T; Harrer E; Trocha AK; Blattner WA; Buchbinder SP; Walker BD
    J Exp Med; 1996 Apr; 183(4):1669-79. PubMed ID: 8666925
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Accumulation of Pol Mutations Selected by HLA-B*52:01-C*12:02 Protective Haplotype-Restricted Cytotoxic T Lymphocytes Causes Low Plasma Viral Load Due to Low Viral Fitness of Mutant Viruses.
    Murakoshi H; Koyanagi M; Chikata T; Rahman MA; Kuse N; Sakai K; Gatanaga H; Oka S; Takiguchi M
    J Virol; 2017 Feb; 91(4):. PubMed ID: 27903797
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Different HLA-B27 subtypes present the same immunodominant Epstein-Barr virus peptide.
    Brooks JM; Murray RJ; Thomas WA; Kurilla MG; Rickinson AB
    J Exp Med; 1993 Sep; 178(3):879-87. PubMed ID: 7688791
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Extensive HLA class I allele promiscuity among viral CTL epitopes.
    Frahm N; Yusim K; Suscovich TJ; Adams S; Sidney J; Hraber P; Hewitt HS; Linde CH; Kavanagh DG; Woodberry T; Henry LM; Faircloth K; Listgarten J; Kadie C; Jojic N; Sango K; Brown NV; Pae E; Zaman MT; Bihl F; Khatri A; John M; Mallal S; Marincola FM; Walker BD; Sette A; Heckerman D; Korber BT; Brander C
    Eur J Immunol; 2007 Sep; 37(9):2419-33. PubMed ID: 17705138
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Promiscuous CTL recognition of viral epitopes on multiple human leukocyte antigens: biological validation of the proposed HLA A24 supertype.
    Burrows SR; Elkington RA; Miles JJ; Green KJ; Walker S; Haryana SM; Moss DJ; Dunckley H; Burrows JM; Khanna R
    J Immunol; 2003 Aug; 171(3):1407-12. PubMed ID: 12874232
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cytotoxic T cell responses to multiple conserved HIV epitopes in HIV-resistant prostitutes in Nairobi.
    Rowland-Jones SL; Dong T; Fowke KR; Kimani J; Krausa P; Newell H; Blanchard T; Ariyoshi K; Oyugi J; Ngugi E; Bwayo J; MacDonald KS; McMichael AJ; Plummer FA
    J Clin Invest; 1998 Nov; 102(9):1758-65. PubMed ID: 9802890
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Conserved CTL epitopes within EBV latent membrane protein 2: a potential target for CTL-based tumor therapy.
    Lee SP; Tierney RJ; Thomas WA; Brooks JM; Rickinson AB
    J Immunol; 1997 Apr; 158(7):3325-34. PubMed ID: 9120290
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Epitope-dependent selection of highly restricted or diverse T cell receptor repertoires in response to persistent infection by Epstein-Barr virus.
    Campos-Lima PO; Levitsky V; Imreh MP; Gavioli R; Masucci MG
    J Exp Med; 1997 Jul; 186(1):83-9. PubMed ID: 9207000
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effective recognition of HIV-1-infected cells by HIV-1 integrase-specific HLA-B∗4002-restricted T cells.
    Watanabe T; Murakoshi H; Gatanaga H; Koyanagi M; Oka S; Takiguchi M
    Microbes Infect; 2011 Feb; 13(2):160-6. PubMed ID: 20971209
    [TBL] [Abstract][Full Text] [Related]  

  • 51. HLA Alleles Associated with Delayed Progression to AIDS Contribute Strongly to the Initial CD8(+) T Cell Response against HIV-1.
    Altfeld M; Kalife ET; Qi Y; Streeck H; Lichterfeld M; Johnston MN; Burgett N; Swartz ME; Yang A; Alter G; Yu XG; Meier A; Rockstroh JK; Allen TM; Jessen H; Rosenberg ES; Carrington M; Walker BD
    PLoS Med; 2006 Oct; 3(10):e403. PubMed ID: 17076553
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Relative dominance of epitope-specific cytotoxic T-lymphocyte responses in human immunodeficiency virus type 1-infected persons with shared HLA alleles.
    Day CL; Shea AK; Altfeld MA; Olson DP; Buchbinder SP; Hecht FM; Rosenberg ES; Walker BD; Kalams SA
    J Virol; 2001 Jul; 75(14):6279-91. PubMed ID: 11413294
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Identification of Immunodominant HIV-1 Epitopes Presented by HLA-C*12:02, a Protective Allele, Using an Immunopeptidomics Approach.
    Chikata T; Paes W; Akahoshi T; Partridge T; Murakoshi H; Gatanaga H; Ternette N; Oka S; Borrow P; Takiguchi M
    J Virol; 2019 Sep; 93(17):. PubMed ID: 31217245
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Relative dominance of HLA-B*07 restricted CD8+ T-lymphocyte immune responses to human cytomegalovirus pp65 in persons sharing HLA-A*02 and HLA-B*07 alleles.
    Lacey SF; Villacres MC; La Rosa C; Wang Z; Longmate J; Martinez J; Brewer JC; Mekhoubad S; Maas R; Leedom JM; Forman SJ; Zaia JA; Diamond DJ
    Hum Immunol; 2003 Apr; 64(4):440-52. PubMed ID: 12651070
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Identification of HLA-C restricted, HIV-1-specific CTL epitopes by peptide induced upregulation of HLA-C expression.
    Stoll A; Bergmann S; Mummert C; Mueller-Schmucker SM; Spriewald BM; Harrer EG; Harrer T
    J Immunol Methods; 2015 Mar; 418():9-18. PubMed ID: 25633660
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Evidence of HIV-1 adaptation to HLA-restricted immune responses at a population level.
    Moore CB; John M; James IR; Christiansen FT; Witt CS; Mallal SA
    Science; 2002 May; 296(5572):1439-43. PubMed ID: 12029127
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Recognition patterns of HLA-A2-restricted human immunodeficiency virus-1-specific cytotoxic T-lymphocytes in a cohort of HIV-1-infected individuals.
    Schmitt-Haendle M; Bachmann O; Harrer E; Schmidt B; Bäuerle M; Harrer T
    Viral Immunol; 2005; 18(4):627-36. PubMed ID: 16359229
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Presence of HLA-C-restricted cytotoxic T-lymphocyte responses in long-term nonprogressors infected with human immunodeficiency virus.
    Nehete PN; Lewis DE; Tang DN; Pollack MS; Sastry KJ
    Viral Immunol; 1998; 11(3):119-29. PubMed ID: 9918403
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Influence of HLA-B57 on clinical presentation and viral control during acute HIV-1 infection.
    Altfeld M; Addo MM; Rosenberg ES; Hecht FM; Lee PK; Vogel M; Yu XG; Draenert R; Johnston MN; Strick D; Allen TM; Feeney ME; Kahn JO; Sekaly RP; Levy JA; Rockstroh JK; Goulder PJ; Walker BD
    AIDS; 2003 Dec; 17(18):2581-91. PubMed ID: 14685052
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Selection of escape mutation by Pol154-162-specific cytotoxic T cells among chronically HIV-1-infected HLA-B*5401-positive individuals.
    Hashimoto M; Kitano M; Honda K; Koizumi H; Dohki S; Oka S; Takiguchi M
    Hum Immunol; 2010 Feb; 71(2):123-7. PubMed ID: 19891998
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.